P/E ratio for PerkinElmer (PKI)
P/E ratio as of March 2023 (TTM): 27.9
According to PerkinElmer 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.9193. At the end of 2021 the company had a P/E ratio of 25.1.
P/E ratio history for PerkinElmer from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 25.1 | 13.88% |
| 2020 | 22.0 | -53.52% |
| 2019 | 47.4 | 29.69% |
| 2018 | 36.6 | 33.01% |
| 2017 | 27.5 | 12.79% |
| 2016 | 24.4 | -14.38% |
| 2015 | 28.5 | -9.01% |
| 2014 | 31.3 | 11.34% |
| 2013 | 28.1 | -45.6% |
| 2012 | 51.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 31.3 | 12.27% | 🇺🇸 USA |
 Agilent Technologies A | 29.9 | 7.13% | 🇺🇸 USA |
 Becton Dickinson BDX | 45.5 | 63.05% | 🇺🇸 USA |
 Illumina ILMN | -8.25 | -129.56% | 🇺🇸 USA |
 Waters Corporation WAT | 26.2 | -6.03% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 Bruker BRKR | 41.5 | 48.74% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -3.87 | -113.86% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.